GlucoTrack

GlucoTrack PP&E per Employee

The PP&E per Employee of GlucoTrack (GCTK) as of Oct 26, 2026 is 13,333.33 USD. In the previous year, PP&E per Employee was 36,333.33 USD — a change of -63.30% (lower).

PP&E per Employee

13,333.33USD

YoY

-63.30%

Last updated:

PP&E per Employee of GlucoTrack is 2022 13,333.33 USD. PP&E per Employee of GlucoTrack was 2021 36,333.33 USD. It decreases by -63.30% lower compared to the previous year.

The GlucoTrack PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2017
72,248.67 USD
Jan 1, 2018
49,926.33 USD
Jan 1, 2019
107,000.00 USD
Jan 1, 2020
105,000.00 USD
Jan 1, 2021
36,333.33 USD
Jan 1, 2022
13,333.33 USD
The GlucoTrack PP&E per Employee history
YEARPP&E per EmployeeYoY
13,333.33USD-63.30%
36,333.33USD-65.40%
105,000.00USD-1.87%
107,000.00USD+114.32%
49,926.33USD-30.90%
72,248.67USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GlucoTrack Stock analysis

What does GlucoTrack do? GlucoTrack, Inc. makes money by selling non-invasive glucose monitoring devices and related software solutions to people with diabetes and pre-diabetes. The company's GlucoTrack device provides glucose level readings without finger sticks, targeting Type II diabetes and prediabetes users. It also develops an implantable continuous glucose monitor for Type I diabetes and insulin-dependent Type II diabetes patients. The firm offers companion applications and cloud-based solutions to deliver real-time, data-driven tools for diabetes management. Its primary customers are individuals managing diabetes through non-invasive monitoring solutions, with a focus on Type II diabetes and pre-diabetes segments. GlucoTrack, Inc. generates revenue through the commercialization of its non-invasive glucose monitor and the development of its implantable continuous glucose monitor. The company's products are designed for specific diabetes segments: Type II diabetes and prediabetes users for the GlucoTrack device, and Type I diabetes and insulin-dependent Type II diabetes patients for the implantable monitor. The firm's cloud-based platform and companion apps are integral to its service offering, providing personalized diabetes management tools. Revenue streams include device sales and software services for these targeted user groups. The company's business model centers on direct sales of its GlucoTrack device and implantable monitor to diabetes patients. It focuses on Type II diabetes and prediabetes for the non-invasive monitor, while the implantable version targets Type I diabetes and insulin-dependent Type II diabetes. The firm's cloud-based solutions and companion applications are sold as part of the overall diabetes management platform. Revenue is derived from both hardware sales and subscription-based software services for these specific patient segments. GlucoTrack is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GlucoTrack stock

PP&E per Employee of GlucoTrack is 13,333.33 USD in 2022.

PP&E per Employee of GlucoTrack changed from 36,333.33 USD to 13,333.33 USD, representing a -63.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee GlucoTrack since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's GlucoTrack historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — GlucoTrack

All Key Metrics — GlucoTrack